Register Now
Youtube Linkedin Facebook
dxpx general logo white text
Leonardo Royal Hotel Munich, Germany | February 5th - February 6th, 2026

DxPx Europe '26

Register for DxPx Europe ’26

Startups, Growth and Strategic companies in the Diagnostics, Digital Health, Precision Medicine, and Life Sciences Tools space come to DxPx to meet with potential investors, discover new technologies and network with their peers.

Registration includes:

  • Networking receptions on February 5th & 6th 
  • Full day of in-person meetings in the Leonardo Royal Munich on February 6th, 2026
  • Partnering Platform to schedule 1×1 in-person meetings
  • Access to DxPx exhibitor area & panel discussions
Download Our Brochure for Startups

Important Note on Ticket Categories

At DxPx, companies focusing on providing services (rather than producing or developing their own tangible assets) are classified as Service Providers. This includes, but is not limited to:

  • Fundraising agencies
  • Corporate finance advisory firms
  • Strategy consultancies
  • CROs, CMDOs
  • Engineering agencies


Such companies must register under the Service Provider ticket category. They are not eligible for Startup, Industry, or Investor tickets or any discounts for these.

As outlined in our general terms and conditions, DxPx reserves the right to reassign tickets to the correct category and charge the applicable price difference. We kindly ask all participants to register under the appropriate category to avoid additional charges.

Thank you for your understanding and cooperation.

Note: A Standard Startup Ticket is required to attend the networking/lunch events. 

Tickets

The numbers below include tickets for this event already in your cart. Clicking "Get Tickets" will allow you to edit any existing attendee information as well as change ticket quantities.
On Sale
DxPx EU '26 Exhibitor Booth
Includes 2 free Startup DxPx registrations with full access to 1x1 partnering, DxPx panels, both receptions and networking.
$ 3,500 $ 2,195
Unlimited
On Sale
DxPx EU '26 Standard Startup Ticket
Includes access to partnering app to schedule one-on-one meetings, food & drinks, attendance to all panel discussions and 42PLUS1 competition.
$ 1,200 $ 755
Unlimited
On Sale
DxPx EU '26 Standard Growth Company
Includes access to partnering app to schedule one-on-one meetings, food & drinks, attendance to all panel discussions and 42PLUS1 competition.
$ 1,200 $ 755
Unlimited
On Sale
DxPx EU '26 Standard Accelerators/TTOs Ticket
Please inquire about bundle packages for portfolio companies.
$ 1,350 $ 850
Unlimited
On Sale
DxPx EU '26 Institutional Investor Ticket
In the context of DxPx, this includes: VCs (Venture Capitalists), CVCs (Corporate Venture Capitalists) and PEs (Private Equity Firms)
$ 1,350 $ 850
Unlimited
On Sale
DxPx EU '26 Business Angel & Family Office Investor Ticket
Business Angels and Family Offices at DxPx are defined as private investors or investment entities with a proven track record of actively investing in startups or growth-stage companies. DxPx values the integrity of its investor network and reserves the right to decline registrations in these categories if applicants cannot demonstrate genuine and verifiable investment activity.
$ 500 $ 315
Unlimited
DxPx EU '26 SLS Angels Investor Ticket
Exclusive for members of SLS Angels.
$ 0
Unlimited
On Sale
DxPx EU '26 Standard Industry Company Ticket
Diagnostics & Digital health, Precision Medicine and Research Tools provider
$ 1,500 $ 940
Unlimited
DxPx EU '26 Standard Service Provider Ticket
f.e. Corporate Finance Advisors, CMOs & Law firms.
$ 4,500
Unlimited
On Sale
DxPx EU '26 Tech Pillar
The Tech Pillar is a 2.5m x 1m freestanding cardboard display, designed to showcase your startup’s partnering opportunities at DxPx. Use the pillar to highlight your value proposition, target industries, and specific benefits for potential partners.
$ 450 $ 285
Unlimited
On Sale
DxPx EU '26 Company Presentation

Showcase your company’s innovation and growth potential with a 20-minute presentation in an exclusive breakout room at DxPx. These presentations are accessible only to investors and industry partners, providing a focused and confidential environment to pitch your business, highlight your value proposition, and discuss partnership opportunities. Companies can present to an open registration audience but select 16 participants for a more intimate dialogue.

$ 2,000 $ 1,255
Unlimited
Quantity: 0
Total: $ 0

Investors & Industry Companies in Attendance at DxPx Events

Date & Location:

Reception: Thursday, February 5th, 2026
Partnering Day & 42PLUS1: Friday, February 6th, 2026

Leonardo Royal Hotel Munich
Moosacher Straße 90 | 80809 München | Germany

Don't miss our investor conferences & early-stage investing events:

dxpx us adlm logos
DxPx US

DxPx Industry & Investor Conference US:
4 Days In-Person

July 29 - Aug. 1, 2024
Chicago, IL
In the ADLM

Stay up to date and sign up for our latest news:

Next: DxPx U.S. 2025
  • 3 Days In-Person
  • July 29 - 31, 2025
  • McCormick Place
    Convention Center
    Chicago, Illinois, USA
Next: DxPx EU 2026
  • 2 Days In-Person
  • Reception: February 5, 2026
    Partnering Day & 42PLUS1:
    February 6, 2026
  • Munich, Germany
Download Brochure
DxPx media
Useful links

© Copyright DxPx 2025. All Rights Reserved.

Youtube Linkedin Facebook

Oliver Dick

Oliver brings 30+ years of experience in the life sciences industry, has worked in pharma, biotechnology and in vitro diagnostics. His areas of expertise fall under Supply Chain Management, Planning, Production, QC, QA, Engineering, Technology Transfer and Process Improvement. Amongst his vast experience, Oliver held functions such as Vice President of Global Manufacturing at QIAGEN, Chief Operating Officer at Miltenyi Biotec or Chief Operating Office of Resolve Biosciences. He demonstrated exceptional leadership and expertise in driving manufacturing excellence on a global scale.

Oliver has a proven ability to streamline processes, optimize production efficiency, and foster a culture of innovation. He was responsible for strategy development, scaling, cost control and quality and was part of multiple M&A projects and transfer of many new products from acquisition or own development. Today Oliver offers his expertise mainly through his own Consultancy Service Company ODICON.

Experience

Christoph Brandenberger

Christoph Brandenberger is a Managing Director at BGL and a leader in the firm’s Diagnostics, Research Tools & Medical Devices investment banking group. He has more than 20 years of experience in all aspects of mergers and acquisitions, commercialization and partnering agreements, and private placements.

A native of Austria and fluent in German, Christoph’s investment banking experience, coupled with his background in international business, has made him a sought-after advisor in both the domestic and international healthcare markets.

Prior to joining BGL, Christoph served as managing director for Healthios Capital Markets, LLC. Christoph started his career as a financial analyst for Bank of America Securities.

Experience

John Riddle

John Riddle is a Managing Director and member of the BGL Executive Committee. He has more than 30 years of investment banking and capital markets experience, advising clients across a broad spectrum of mergers and acquisitions, capital markets activities, and strategic assignments.

John leads BGL’s advisory activities in the Healthcare & Life Sciences investment banking group, which comprises both corporate investment banking and real estate capital markets capabilities. Together with his team, John maintains an ongoing coverage effort with broad activity across several sectors, including health facilities, physician services, and ancillary providers; diagnostics and research tools; medical device and products; and select healthcare technology verticals, including payor services, data analytics, and clinical automation.

Experience

Dr. Mirko Stange

Born in Bremen, Germany in 1974, Dr. Mirko Stange is a diagnostics and life sciences expert with a proven track record in turning around and commercializing innovations. He possesses extensive executive management experience, having led diagnostics and biotech startups, as well as developing and conducting consulting products. Following the completion of his Ph.D. in Biochemistry and Biophysics at the University of North Carolina at Chapel Hill, Dr. Stange began his career in 2004 at the strategy consultancy McKinsey. Subsequently, he worked with the turnaround-specialized advisory firm Droege & Comp., primarily serving clients from the pharma and chemistry industry in Germany and Switzerland.

In 2008, he founded an independent Life Sciences consultancy in Germany where, to date, he leads and directs a team of international experts. This team identifies and funds SMEs with high potential for national and international leverage. In addition to his over ten years of experience in independent corporate finance and management consulting, Mirko Stange provides interim management services to selected clients. To date, three companies co-founded and managed/advised by Dr. Stange have been successfully exited. Leveraging his scientific background, he is also a named inventor on several granted and pending patents.

Experience

FName LName

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Experience